Nicholas B Lydon1, Brian J Druker. Show Affiliations » 1. nick.lydon@verizon.net
Abstract
Entities: Chemical
Mesh: See more » BenzamidesDrug DesignDrug Evaluation, Preclinical/methodsFusion Proteins, bcr-abl/antagonists & inhibitorsFusion Proteins, bcr-abl/metabolismHumansImatinib MesylateNeoplasms/drug therapyPiperazines/chemistryPiperazines/pharmacologyPiperazines/therapeutic useProtein-Tyrosine Kinases/antagonists & inhibitorsPyrimidines/chemistryPyrimidines/pharmacologyPyrimidines/therapeutic useStructure-Activity Relationship
Substances: See more » BenzamidesPiperazinesPyrimidinesImatinib MesylateProtein-Tyrosine KinasesFusion Proteins, bcr-abl
Year: 2004 PMID: 15036939 DOI: 10.1016/j.leukres.2003.10.002
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156